Drug-Coated Balloon Angioplasty of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial
The DCB-BIF trial demonstrated that in the treatment of true bifurcation coronary artery lesions, using a drug-coated balloon (DCB) for the side branch after stenting the main branch resulted in a lower one-year risk of the composite endpoint of cardiac death, target vessel-related myocardial infarction (MI), and clinically driven target lesion revascularization (TLR) compared to a non-compliant balloon (NCB), with this difference primarily driven by MI, Dr. Xiaofei Gao and colleagues, Nanjing Medical University, China, reported in the January 7 issue of the Journal of the American College of Cardiology.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations
